Integral Health Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,000
| Closed | -$10.8M | – | 87 |
|
|
2025
Q1 | $10.8M | Buy |
60,000
+5,000
| +9% | +$902K | 1.15% | 25 |
|
|
2024
Q4 | $8.62M | Buy |
+55,000
| New | +$8.62M | 0.73% | 45 |
|
|
2024
Q3 | – | Sell |
-85,000
| Closed | -$15.6M | – | 83 |
|
|
2024
Q2 | $15.6M | Buy |
85,000
+5,000
| +6% | +$918K | 1.48% | 19 |
|
|
2024
Q1 | $14.2M | Sell |
80,000
-5,000
| -6% | -$890K | 1.32% | 30 |
|
|
2023
Q4 | $10.5M | Buy |
85,000
+15,000
| +21% | +$1.86M | 1.44% | 28 |
|
|
2023
Q3 | $8.12M | Buy |
70,000
+8,000
| +13% | +$928K | 1.12% | 36 |
|
|
2023
Q2 | $7.28M | Sell |
62,000
-23,000
| -27% | -$2.7M | 0.9% | 42 |
|
|
2023
Q1 | $6.81M | Sell |
85,000
-30,000
| -26% | -$2.4M | 1.37% | 32 |
|
|
2022
Q4 | $9.11M | Buy |
115,000
+25,000
| +28% | +$1.98M | 1.91% | 21 |
|
|
2022
Q3 | $6.27M | Buy |
90,000
+37,816
| +72% | +$2.64M | 1.22% | 33 |
|
|
2022
Q2 | $3.43M | Buy |
+52,184
| New | +$3.43M | 0.7% | 47 |
|